Establishment Labs Holdings (ESTA) Change in Receivables (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Change in Receivables came in at -$302000.0 in Q1 2026, up 61.03% year-on-year from -$187540.1 in Q1 2025, and down 104.67% quarter-over-quarter from $6.5 million in Q4 2025.
Establishment Labs Holdings (ESTA) Change in Receivables (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Change in Receivables history runs 10 years deep, the most recent figure standing at -$302000.0 for Q1 2026.
- On a quarterly basis, Change in Receivables rose 61.03% year-over-year to -$302000.0 in Q1 2026; TTM through Mar 2026 was $11.9 million, a 42.85% decrease from a year earlier, with the FY2025 full-year figure at $11.5 million, down 56.36% from the prior year.
- Change in Receivables declined to -$302000.0 in Q1 2026 per ESTA's latest filing, from $6.5 million in the prior quarter.
- Across five years, Change in Receivables topped out at $9.6 million in Q2 2023 and bottomed at -$8.1 million in Q4 2023.
- The 5-year median for Change in Receivables is $4.6 million (2024), against an average of $3.6 million.
- Across the five-year window, Change in Receivables surged 2550.0% in 2022 and slumped 429.67% in 2023, its largest moves.
- Year by year, Change in Receivables stood at $2.4 million in 2022, then slumped by 429.67% to -$8.1 million in 2023, then soared by 163.71% to $5.1 million in 2024, then rose by 25.79% to $6.5 million in 2025, then sank by 104.67% to -$302000.0 in 2026.
- Per Business Quant, the three latest ESTA Change in Receivables figures stand at -$302000.0 (Q1 2026), $6.5 million (Q4 2025), and $1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | -302,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -302,000.00 |
| Mar 31, 2026 | -302,000.00 |
| Dec 31, 2025 | 6.47 Mn |
| Dec 31, 2025 | 6.47 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 4.46 Mn |
| Jun 30, 2025 | 4.46 Mn |
| Mar 31, 2025 | -775,000.00 |
| Mar 31, 2025 | -775,000.00 |
| Dec 31, 2024 | 5.15 Mn |
| Dec 31, 2024 | 5.15 Mn |
| Sep 30, 2024 | 6.91 Mn |
| Sep 30, 2024 | 6.91 Mn |
| Jun 30, 2024 | 9.62 Mn |
| Jun 30, 2024 | 9.62 Mn |
| Mar 31, 2024 | 4.61 Mn |
| Mar 31, 2024 | 4.61 Mn |
| Dec 31, 2023 | -8.08 Mn |
| Dec 31, 2023 | -8.08 Mn |